Lisdexamfetamine for methamphetamine withdrawal (OLAM trial) Oral Lisdexamfetamine for the treatment of Acute Methamphetamine withdrawal (the OLAM trial): A randomised controlled trial
Ketamine-assisted psychotherapy for methamphetamine use disorder (KAPPA) An open-label, safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder
Medication-assisted psychotherapy for methamphetamine use disorder Examining emerging research into psilocybin- and ketamine-assisted psychotherapy.
Methamphetamine treatment: new and upcoming options An update on new and upcoming treatment options for clinicians, researchers and people who use methamphetamine.
GHB Insights for service providers The effects of GHB, its use in Australia, and harm reduction & treatment principles.